Philips books EUR 288 million to settle US case over sleep apnoea devices
DutchNews · · AI-summarised by FinFlash
Philips reached an agreement in principle with the US Justice Department worth EUR 288 million over defective Respironics sleep apnoea devices, disclosing the figure in its quarterly results. The recall covered 5.5 million machines and 17 million masks. Third-quarter sales rose 3% to EUR 4.4 billion, while profit fell to EUR 28 million from EUR 187 million, partly because of the settlement. Chief executive Roy Jakobs called it a very important step.
So What?
Removing a long-running legal overhang is a positive for Philips' risk profile, though the charge dented quarterly profit. Watch final settlement terms and order momentum.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.